CTOs on the Move

Nanoscope Therapeutics

www.nanostherapeutics.com

 
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Health Benchmarks Inc

Health Benchmarks Inc is a Woodland Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lourdes Hospital

Lourdes has as many faces as there are people in the community it serves. With its spiritual Catholic faith, Lourdes Hospital has provided compassionate care to those in need since 1925. In Binghamton, NY, our health system includes an Ambulatory Surgery Center, Home Care and Hospice services, and a Regional Cancer Center. Reaching beyond these boundaries, Lourdes has established a network of primary care physicians at convenient sites throughout the region. Our Mission In Motion program, provides women`s health services with a mobile medical van, making health care accessible to rural populations.

Orbus Therapeutics

Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.

Babson Diagnostics

Babson Diagnostics is bringing medically-accurate blood testing to the pharmacy, and empowering people to take charge of their health by reimagining the entire blood testing process from ordering, collection, handling, analyzing, and reporting of results, making it less invasive and more convenient, accessible, and patient-centered.

Roselani Place

Roselani Place is a Kahului, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.